Cover image not available

Comment on the National Institute for Clinical Excellence technology appraisal Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease

Health Technology Board for Scotland

Publication Data

Title Comment on the National Institute for Clinical Excellence technology appraisal Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease
Author Health Technology Board for Scotland
Publisher Health Technology Board for Scotland
Publication date 2001
Publication location Glasgow
Language English

Descriptive Notes

Cover title.

Topics

Cholinesterase inhibitors :: Therapeutic use
Alzheimer's disease :: Treatment :: Scotland

Catalogue Data

OBNB ID GBA322364
ISBN 10 1903961009
ISBN 13 n/a
Type BibliographicResource, Book

ISBD

P1053 8 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Comment on the National Institute for Clinical Excellence technology appraisal Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease by Health Technology Board for Scotland. ISBN 1903961009. Published by Health Technology Board for Scotland in 2001. Publication and catalogue information, links to buy online and reader comments.